VIDEO: ViaLase shares update on femtosecond laser trabeculotomy for glaucoma
SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Richard A. Lewis, MD, of ViaLase discusses femtosecond laser image-guided high-precision trabeculotomy for the treatment of glaucoma.
According to Lewis, the company completed a clinical trial investigating the safety of FLigHT. In addition, ViaLase has completed enrollment in the pivotal VIA-002 trial comparing FLigHT to selective laser trabeculoplasty for the treatment of primary open-angle glaucoma.
“It’s a unique treatment for glaucoma. It does not require an incision, yet we create a trabeculotomy through the trabecular meshwork,” he said.
Editor's note: This article was updated on Nov. 30, 2023, to clarify the progress of the clinical trials.
Collapse
Lewis R. ViaLase, Inc. Presented at: Eyecelerator@AAO; Nov. 2, 2023; San Francisco.
Read more about